Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief Medical Advisor to the White House admitted Thursday there is no data showing COVID-19 booster shots actually lower the rates of hospitalization or death in children. During a Senate Health, Education, Labor and Pensions Committee hearing, Senator Rand Paul […]
Vaccines
Fauci Tests Positive for COVID After Four Failed Shots, Praises Boosters at Senate Hearing
In what is an awkward but expected turn of events, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief Medical Advisor to President Biden on the coronavirus pandemic has tested positive for COVID-19. The NIAID on Wednesday said in a statement that Fauci, 81, tested positive for the […]
FDA Panel Recommends Pfizer and Moderna COVID Shots for Babies and Young Kids, Ignores Risks
The U.S. Food and Drug Administration’s (FDA) vaccine advisory panel today unanimously voted 21-0 to recommend Pfizer and Moderna’s COVID-19 vaccines for infants and young children, stating the totality of the evidence available shows the benefits of the vaccines outweigh the risks. Pfizer’s three-dose vaccine would cover children 6 months to 5 years old, while […]
FDA Advisors Unanimously Recommend Moderna’s COVID Vaccine for Kids 6 to 17, Completely Ignore Data
A vaccine committee advising the U.S. Food and Drug Administration (FDA) on Tuesday unanimously recommended Moderna’s COVID-19 vaccine for children ages 6 to 17 after determining the benefits of the vaccine outweigh the risks. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 22 to 0 to recommend Moderna’s two-dose vaccine for 6- to 11-year-olds at half the […]
FDA Experts Recommend Emergency Authorization of Novavax COVID Vaccine, Ignore Risk of Heart Inflammation
The U.S. Food and Drug Administration’s (FDA) vaccine advisors recommended the Novavax COVID-19 vaccine for emergency use authorization on Tuesday, paving the way for a fourth U.S. vaccine. The panel’s vote was 21 in favor of authorizing Novavax and one abstention. However, FDA authorization could be delayed because the company informed the agency just four […]